Showing results (511-520 of 582) with videos related to
Sort By:
Pageof 59
Blood|November 15, 2021
Phase 1/dose expansion trial of brentuximab vedotin and lenalidomide in relapsed or refractory diffuse large B-cell lymphomaJeffrey P Ward, Melissa M Berrien-Elliott, Felicia Gomez, et al.Plos One|July 17, 2015
Decoupling of the PI3K Pathway via Mutation Necessitates Combinatorial Treatment in HER2+ Breast CancerJames E Korkola, Eric A Collisson, Laura Heiser, et al.Cell Reports|September 30, 2016
Truncating Prolactin Receptor Mutations Promote Tumor Growth in Murine Estrogen Receptor-Alpha Mammary CarcinomasObi L Griffith, Szeman Ruby Chan, Malachi Griffith, et al.Plos Pathogens|January 31, 2025
CD16 and CD57 expressing gamma delta T cells in acute HIV-1 infection are associated with the development of neutralization breadthGina L Griffith, Kawthar Machmach, Ningbo Jian, et al.Cancer Discovery|June 26, 2012
The transcription factor ZNF217 is a prognostic biomarker and therapeutic target during breast cancer progressionLaurie E Littlepage, Adam S Adler, Hosein Kouros-Mehr, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2026
NT-I7, a long-acting interleukin-7, increases lymphocyte counts and induces CD8+ T cell clonotype expansion in patients with newly diagnosed high-grade gliomasOmar H Butt, Kartik Singhal, Jingqin Luo, et al.Cancer Discovery|October 6, 2021
Characterization of the Genomic and Immunologic Diversity of Malignant Brain Tumors through Multisector AnalysisMaximilian O Schaettler, Megan M Richters, Anthony Z Wang, et al.Plos One|October 12, 2017
Correction: Decoupling of the PI3K Pathway via Mutation Necessitates Combinatorial Treatment in HER2+ Breast CancerJames E Korkola, Eric A Collisson, Laura M Heiser, et al.Annals of Internal Medicine|December 29, 1998
Use of the acute cardiac ischemia time-insensitive predictive instrument (ACI-TIPI) to assist with triage of patients with chest pain or other symptoms suggestive of acute cardiac ischemia. A multicenter, controlled clinical trialH P Selker, J R Beshansky, J L Griffith, et al.Human Mutation|April 27, 2022
Large scale genotype- and phenotype-driven machine learning in Von Hippel-Lindau diseaseAndreea Chiorean, Kirsten M Farncombe, Sean Delong, et al.Pageof 59